BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36615523)

  • 1. A Natural CHI3L1-Targeting Compound, Ebractenoid F, Inhibits Lung Cancer Cell Growth and Migration and Induces Apoptosis by Blocking CHI3L1/AKT Signals.
    Hong DE; Yu JE; Lee JW; Son DJ; Lee HP; Kim Y; Chang JY; Lee DW; Lee WK; Yun J; Han SB; Hwang BY; Hong JT
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
    Lee YS; Yu JE; Kim KC; Lee DH; Son DJ; Lee HP; Jung JK; Kim ND; Ham YW; Yun J; Han SB; Hong JT
    Mol Oncol; 2022 Jan; 16(2):508-526. PubMed ID: 34758182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
    Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
    Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.
    Lee CM; He CH; Nour AM; Zhou Y; Ma B; Park JW; Kim KH; Dela Cruz C; Sharma L; Nasr ML; Modis Y; Lee CG; Elias JA
    Nat Commun; 2016 Sep; 7():12752. PubMed ID: 27629921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
    Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
    Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 8. CHI3L1 induces autophagy through the JNK pathway in lung cancer cells.
    Hong DE; Yu JE; Yoo SS; Yeo IJ; Son DJ; Yun J; Han SB; Hong JT
    Sci Rep; 2023 Jun; 13(1):9964. PubMed ID: 37340009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
    Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
    Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway.
    Park KR; Yun HM; Hong JT
    Int J Biol Sci; 2020; 16(2):330-341. PubMed ID: 31929760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Wang F; Mao Y; You Q; Hua D; Cai D
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
    Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee SO; Lee MH; Lee KR; Lee EO; Lee HJ
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845749
    [No Abstract]   [Full Text] [Related]  

  • 17. NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    Yang Y; Ikezoe T; Nishioka C; Bandobashi K; Takeuchi T; Adachi Y; Kobayashi M; Takeuchi S; Koeffler HP; Taguchi H
    Br J Cancer; 2006 Dec; 95(12):1653-62. PubMed ID: 17133272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.